ATE108335T1 - Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen. - Google Patents

Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.

Info

Publication number
ATE108335T1
ATE108335T1 AT90610014T AT90610014T ATE108335T1 AT E108335 T1 ATE108335 T1 AT E108335T1 AT 90610014 T AT90610014 T AT 90610014T AT 90610014 T AT90610014 T AT 90610014T AT E108335 T1 ATE108335 T1 AT E108335T1
Authority
AT
Austria
Prior art keywords
hiv
prevention
treatment
infection
kit
Prior art date
Application number
AT90610014T
Other languages
English (en)
Inventor
Franklin Volvovitz
Original Assignee
Microgenesys Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Microgenesys Inc filed Critical Microgenesys Inc
Application granted granted Critical
Publication of ATE108335T1 publication Critical patent/ATE108335T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT90610014T 1989-03-03 1990-03-01 Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen. ATE108335T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31827289A 1989-03-03 1989-03-03

Publications (1)

Publication Number Publication Date
ATE108335T1 true ATE108335T1 (de) 1994-07-15

Family

ID=23237447

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90610014T ATE108335T1 (de) 1989-03-03 1990-03-01 Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.

Country Status (8)

Country Link
EP (1) EP0385909B1 (de)
JP (1) JPH03163027A (de)
AT (1) ATE108335T1 (de)
AU (1) AU635001B2 (de)
CA (1) CA2011299A1 (de)
DE (1) DE69010523D1 (de)
DK (1) DK0385909T3 (de)
IL (1) IL93599A0 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5456924A (en) * 1988-12-23 1995-10-10 Immunotec Research Corporation Ltd. Method of treatment of HIV-seropositive individuals with dietary whey proteins
WO1991002743A1 (en) * 1989-08-23 1991-03-07 The General Hospital Corporation Non-human primate cd4 polypeptides, fusions thereof, dna encoding, and uses thereof
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
EP0636173B1 (de) * 1991-05-31 1998-09-02 Genentech, Inc. Behandlung der hiv-assoziierten immun-thrombopenie purpura
ATE207760T1 (de) * 1993-05-07 2001-11-15 Akzo Nobel Nv Hiv immunogene komplexe
EP0893507A1 (de) * 1997-07-25 1999-01-27 Institut Gustave Roussy Verwendung von MHC Klass II Liganden (CD4 und LAG-3) als Adjuvanz für Impfungen und von LAG-3 in der Behandlung von Krebs
CN111405910A (zh) * 2017-05-10 2020-07-10 阿尔巴朱纳治疗有限公司 具有高HIV抗病毒和免疫调节双重活性的Fc融合蛋白衍生物

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US344304A (en) * 1886-06-22 Spindle-support
FR2606029B2 (fr) * 1986-04-08 1989-02-03 Transgene Sa Vecteur viral et adn recombinant codant pour une glycoproteine du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la glycoproteine, glycoproteine obtenue, vaccin et anticorps obtenus
IE872748L (en) * 1986-10-16 1988-04-16 Arjomari Europ Polypeptides derived from the evvelope gene of human¹immunodeficiency virus in recombinant baculovirus infected¹insect cells
EP0272858A3 (de) * 1986-12-15 1989-07-12 Repligen Corporation Rekombinante HIV-Hüllen-Proteine, hergestellt in Insektenzellen
AU609447B2 (en) * 1987-02-19 1991-05-02 Nissin Shokuhin Kabushiki Kaisha Methods and materials for hiv detection and therapy
JPH01502751A (ja) * 1987-03-23 1989-09-21 ハイヴァー　リミテッド 新規ワクチン類

Also Published As

Publication number Publication date
JPH03163027A (ja) 1991-07-15
AU5061090A (en) 1990-11-01
CA2011299A1 (en) 1990-09-03
EP0385909B1 (de) 1994-07-13
AU635001B2 (en) 1993-03-11
DK0385909T3 (da) 1994-08-15
EP0385909A3 (de) 1991-04-10
EP0385909A2 (de) 1990-09-05
IL93599A0 (en) 1990-12-23
DE69010523D1 (de) 1994-08-18

Similar Documents

Publication Publication Date Title
ATE182271T1 (de) Arzneimittel zur behandlung von krebs, aids und viruserkrankungen
NO890259L (no) Fremgangsmaate for fremstilling av terapeutisk aktive etylfenoksyacetamider.
DK0951473T3 (da) Cyclosporinderivat, fremstilling af dette og farmaceutiske præparater indeholdende dette
ES2051641A1 (es) Procedimientos para la preparacion de compuestos derivados de tiourea.
ES2130114T3 (es) 5,11-dihidro-6h-dipirido(3,2-b:2',3'-e)(1,4)diazepinas y su uso en la prevencion o tratamiento de infeccion por hiv.
HU901585D0 (en) Method for treatment of viral infections using functional derivatives of icam-1
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DE69533673D1 (de) Behandlung und prävention von helicobacter-infektionen
ATE78696T1 (de) Arzneimittelzubereitung zur behandlung des immunmangels.
ATE100098T1 (de) Nukleoside, ihre herstellung und pharmazeutische zusammenstellungen.
ATE77554T1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
ATE139531T1 (de) Arylsubstituierte rhodaninderivate
DE68923169D1 (de) Verwendung von fluor enthaltenden Pyridoncarbonsäure-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von HIV infektionen.
ATE108335T1 (de) Kit oder zusammensetzung zur vorbeugung oder behandlung von hiv-1 infektionen.
DK0406745T3 (da) Antibiotiske GE 2270 faktorer A1, A2, A3 og H
GR3014952T3 (en) Use of an immunoglobulin-containing composition in the prophylaxis and therapy of AIDS of human.
DE3874606D1 (de) Behandlung von viraler infektion.
ATE71299T1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
ATE196424T1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
ATE121935T1 (de) D-asparaginsäure-beta-hydroxamat zur behandlung viraler infektionen und tumoren.
EP0392666A3 (de) Anti-HIV Zusammensetzungen
BR9708720A (pt) Composição farmacêutica e processo para o tratamento de demência por hiv.
ATE72397T1 (de) Pharmazeutische zusammensetzungen zur behandlung von hyperproliferativer hautkrankheit.
ES2062266T3 (es) Uso de quinolil- e isoquinoliloxazol-2-onas para la obtencion de un medicamento destinado para la prevencion de infecciones por virus envueltos por glicoproteinas.
ATE59776T1 (de) Pharmazeutische zusammensetzung und behandlung.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties